New Thought Leader for Agilent

Skip to Navigation

Blog Post

  • Published: Dec 14, 2015
  • Author: Jon Evans
  • Suppliers: Agilent Technologies
  • Channels: HPLC / Detectors / Ion Chromatography / Sample Preparation / Proteomics & Genomics / Electrophoresis / Gas Chromatography / Laboratory Informatics / NMR Knowledge Base / Proteomics / Infrared Spectroscopy / X-ray Spectrometry / Raman / MRI Spectroscopy / UV/Vis Spectroscopy / Base Peak / Atomic / Chemometrics & Informatics

View comments on this post

Agilent Technologies has presented its latest Thought Leader Award to Jeffrey Gordon, director of the Center for Genome Sciences and Systems Biology at Washington University School of Medicine in St. Louis, US. Agilent's Thought Leader program promotes fundamental scientific advances by contributing financial support, products and expertise to the research of influential thought leaders in the life sciences and chemical analysis.

Gordon is being recognized for his pioneering research into the mutually beneficial relationship between the human body and the tens of trillions of microbes that inhabit the gastrointestinal tract. The award, which includes funding and cutting-edge solutions from Agilent, will enhance his efforts to elucidate the role of the gut microbiome and its metabolic products in health and disease.

Gordon and his lab will use Agilent solutions – state-of-the-art gas and liquid chromatographs, mass spectrometers and analytical software – to tease apart the complex relationships that exist between the gut microbiome and the body’s physiology. More specifically, they will use Agilent solutions to develop GC/MS, LC/MS and analytical workflows for the study of microbial metabolites produced by the human gut microbiome.

“We are extremely grateful for this special award,” said Gordon. “It will have a catalytic effect on our ability to mine the gut microbiome for metabolic products that shape many facets of our human biology. Improving the nutritional status of infants and children, as well as adults, is a pressing global health problem during this time of rapid population growth and challenges to sustainable agriculture. We believe that characterizing the metabolic machinery of the gut microbiome is a key step in the discovery of new ways to diagnose and more effectively treat malnutrition, and in developing affordable, more nutritious foods that improve human health worldwide.”

“Dr. Gordon’s commitment to improving human health, especially that of malnourished children, is one that Agilent is proud to support,” said Todd Christian, Agilent’s senior director of global marketing. “With this award, Dr. Gordon’s laboratory will be fully equipped to reliably collect, analyze, identify and quantify essential metabolomics data, turning it into important scientific insights.”

(Photo of Jeffrey Gordon courtesy of Washington University in St. Louis.)


There are currently no comments on this post.

Comment Form

You have to log in to comment on this post.

Log in using the form at the top of the page or register here.

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in spectroscopy? Visit our sister site

Copyright © 2020 John Wiley & Sons, Inc. All Rights Reserved